Co-administration of MTX with Folic Acid on the same day did not reduce efficacy compared to FA application one day after MTX. (based on AIA was induced in female Lewis rats)
https://bit.ly/3EL8Z3g
Tweet by Dr. John Cush
Tweet
Related Content
In this session, Dr. Jack Cush reviews methotrexate.
Video transcript available.
Methotrexate (MTX) is the most commonly used DMARD in rheumatoid arthritis (RA); however, there is significant intolerance to this drug among adult RA patients - especially at doses above 15 mg per week.
